Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol. 2018;14(8):476–500. https://doi.org/10.1038/s41574-018-0042-0.
2. Verulashvili IV, Glonti L, Miminoshvili DK, Maniia MN, Mdivani KS. Basal ganglia calcification: clinical manifestations and diagnostic evaluation. Georgian Med News. 2006;140:39–43.
3. Al-Azem H, Khan AA. Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2012;26(4):517–22. https://doi.org/10.1016/j.beem.2012.01.
4. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805–6. https://doi.org/10.1016/S0140-6736(05)78933-9.
5. Kim YS, Park J, Park Y, Hwang K, Koo DL, Kim D, Seo DW. Intracranial cortical calcifications in a focal epilepsy patient with pseudohypoparathyroidism. J Epilepsy Res. 2016;6(1):31–5. https://doi.org/10.14581/jer.16006.